Kate Haviland is CHIEF EXECUTIVE OFFICER of Blueprint Medicines Corp.
Person profile
Roles
Blueprint Medicines
CHIEF EXECUTIVE OFFICER
Fulcrum Therapeutics
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Blueprint Medicines Corp
7 Nov 22
4
Fulcrum Therapeutics, Inc.
29 Jun 22
4
Blueprint Medicines Corp
8 Mar 22
4
Blueprint Medicines Corp
3 Mar 22
4
Blueprint Medicines Corp
15 Dec 21
4
Blueprint Medicines Corp
15 Sep 21
4
Blueprint Medicines Corp
30 Jun 21
4
Fulcrum Therapeutics, Inc.
11 Jun 21
4
Blueprint Medicines Corp
17 Mar 21
4
Blueprint Medicines Corp
5 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Nov 22 | BPMC Blueprint Medicines | Common Stock | Buy | Acquire P | No | No | 43.98 | 1,100 | 48.38 k | 92,281 |
27 Jun 22 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 19,000 | 99.18 k | 19,000 |
7 Mar 22 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | No | 56.18 | 1,048 | 58.88 k | 91,181 |
3 Mar 22 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | No | 60.27 | 1,719 | 103.60 k | 92,229 |
1 Mar 22 | BPMC Blueprint Medicines | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 93,948 |
1 Mar 22 | BPMC Blueprint Medicines | Stock Option Common Stock | Grant | Acquire A | No | No | 61.31 | 80,000 | 4.90 mm | 80,000 |
13 Dec 21 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 96.78 | 94 | 9.10 k | 53,948 |
13 Dec 21 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 97.6 | 411 | 40.11 k | 54,042 |
13 Dec 21 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 98.5 | 210 | 20.69 k | 54,453 |
13 Dec 21 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 99.65 | 285 | 28.40 k | 54,663 |